Small Molecule Control of Morpholino Antisense Oligonucleotide Function Through Staudinger Reduction
Overview
Affiliations
Conditionally activated, caged morpholino antisense agents (cMOs) are tools that enable the temporal and spatial investigation of gene expression, regulation, and function during embryonic development. Cyclic MOs are conformationally gated oligonucleotide analogs that do not block gene expression until they are linearized through the application of an external trigger, such as light or enzyme activity. Here, we describe the first examples of small molecule-responsive cMOs, which undergo rapid and efficient decaging via a Staudinger reduction. This is enabled by a highly flexible linker design that offers opportunities for the installation of chemically activated, self-immolative motifs. We synthesized cyclic cMOs against two distinct, developmentally relevant genes and demonstrated phosphine-triggered knockdown of gene expression in zebrafish embryos. This represents the first report of a small molecule-triggered antisense agent for gene knockdown, adding another bioorthogonal entry to the growing arsenal of gene knockdown tools.
Jin C, Li S, Vallis K, El-Sagheer A, Brown T RSC Chem Biol. 2024; 5(8):738-744.
PMID: 39092443 PMC: 11289880. DOI: 10.1039/d4cb00112e.
Expanding the Genetic Code of Embryos.
Brown W, Davidson L, Deiters A ACS Chem Biol. 2024; 19(2):516-525.
PMID: 38277773 PMC: 10877573. DOI: 10.1021/acschembio.3c00686.
Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors.
Kvorjak M, Ruffo E, Tivon Y, So V, Parikh A, Deiters A ACS Synth Biol. 2023; 12(10):2996-3007.
PMID: 37791909 PMC: 10594876. DOI: 10.1021/acssynbio.3c00320.
Wang Z, Fan X, Mu G, Zhao X, Wang Q, Wang J Mol Ther Nucleic Acids. 2023; 33:548-558.
PMID: 37588686 PMC: 10425675. DOI: 10.1016/j.omtn.2023.07.022.
Antisense Oligonucleotide Activation via Enzymatic Antibiotic Resistance Mechanism.
Darrah K, Albright S, Kumbhare R, Tsang M, Chen J, Deiters A ACS Chem Biol. 2023; 18(10):2176-2182.
PMID: 37326511 PMC: 10592181. DOI: 10.1021/acschembio.3c00027.